We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
47 hedge funds and large institutions have $106M invested in Accelerate Diagnostics in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
317% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 6
90% more capital invested
Capital invested by funds: $55.9M → $106M (+$50.3M)
0% more funds holding
Funds holding: 47 → 47 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Holders
47
Holders Change
–
Holders Change %
0%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
25
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$4.59M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$3.62M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$926K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$838K |
| 5 |
State Street
Boston,
Massachusetts
|
+$703K |
Top Sellers
| 1 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$1.48M |
| 2 |
PA
Para Advisors
New York
|
-$528K |
| 3 |
Morgan Stanley
New York
|
-$311K |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$300K |
| 5 |
Goldman Sachs
New York
|
-$282K |
